A draft update to the US Food and Drug Administration’s guidance document on premarket regulation of medical device cybersecurity clarifies the agency’s expectations around establishing cyber threat protection in submissions for so-called “cyber devices.”
When finalized, the document will become the new Section VII of a guidance document last updated in September 2023. The FDA gained new authority over device cybersecurity in the 2022 omnibus spending bill